Arcutis Biotherapeutics, Inc. (ARQT)

Last Three Months

24-Jan-24 -- 23-Apr-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

18

0

6

+1

0

+2

0

+3

Two Year Chart

24-Apr-22 -- 23-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
15-Feb-24 6:23 PM View:	13-Feb-24 Grant 0	Smither John W Chief Financial Officer		Arcutis Biotherapeutics, Inc. - ARQT	8% 141.39K to 152.76K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 5:12 PM View:	04-Mar-24 Sale (Planned) ($53.18K)	Burnett Patrick See Remarks		Arcutis Biotherapeutics, Inc. - ARQT	217% 85.03K to 269.3K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 5:09 PM View:	04-Mar-24 Sale (Planned) ($165.74K)	Watanabe Todd Franklin See Remarks Director		Arcutis Biotherapeutics, Inc. - ARQT	29% 858.16K to 1.11M	0	0	--	--	Show Txns Hide Txns

06-Mar-24 10:00 PM View:	04-Mar-24 Sale (Planned) ($41.82K)	Matsuda Masaru See Remark		Arcutis Biotherapeutics, Inc. - ARQT	155% 74.63K to 190.42K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 10:00 PM View:	04-Mar-24 Sale (Planned) ($38.57K)	Moore Matthew Richard SVP and Chief Business Officer		Arcutis Biotherapeutics, Inc. - ARQT	167% 54.59K to 146.02K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:28 PM View:	04-Mar-24 Private Purchase $199.99K	Heron Patrick J Director		Arcutis Biotherapeutics, Inc. - ARQT	0% 8.8M to 8.82M	0	0	--	--	Show Txns Hide Txns

11-Apr-24 8:32 PM View:	10-Apr-24 Grant 0	Topper David Joseph Chief Financial Officer		Arcutis Biotherapeutics, Inc. - ARQT	100% 0 to 110.0K	0	0	--	--	Show Txns Hide Txns